Helping Lagos communities switch to cleaner bioethanol cookstoves to cut household smoke and high blood pressure
Community Mobilization for Improved Clean Cookstove Uptake, Household Air Pollution Reduction, and Hypertension Prevention
This project works with communities in Lagos, Nigeria to promote affordable bioethanol clean cookstoves so households can reduce indoor smoke and help lower adults' blood pressure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11141156 on NIH RePORTER |
What this research studies
If you cook with wood, charcoal, or kerosene in Lagos, this project partners with local leaders and health workers to help households adopt affordable bioethanol clean cookstoves. A community advisory board and trained community health extension workers will form community action teams to teach proper use and build local support for sustained adoption. The team will track how many households switch and keep using the stoves and will measure changes in household air pollution and blood pressure over time. The program is run with the Lagos State Ministry of Health and builds on earlier trials that showed blood pressure benefits.
Who could benefit from this research
Good fit: Adults aged 21 and older in Lagos who currently cook with solid fuels or kerosene and are willing to try an affordable bioethanol clean cookstove.
Not a fit: People who already use clean cooking technology, live outside the program areas in Lagos, or are not willing to change their cooking methods are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, more families could have less household air pollution and lower blood pressure, which may reduce the risk of heart disease and stroke.
How similar studies have performed: A prior randomized trial of 271 women in Nigeria showed significant blood pressure reductions and an 80% adoption rate, so this builds on promising evidence.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Ogedegbe, Olugbenga G. — New York University School of Medicine
- Study coordinator: Ogedegbe, Olugbenga G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.